{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-004799","form_type":"8-K","ticker":"ANEB","cik":"0001815974","company_name":"Anebulo Pharmaceuticals, Inc.","filed_at":"2025-04-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.843645+00:00","generated_at":"2026-05-23T14:52:11.619270+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Anebulo regains Nasdaq compliance on private placement share restrictions","bullets":["Nasdaq confirmed compliance with Listing Rule 5635(b) on April 11, 2025.","Removal of voting and transfer restrictions on shares issued in December 2024 private placement was approved by stockholders.","Matter is now closed; no further delisting risk from this issue.","Company disclosed the resolution in an 8-K filed April 15, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-004799","json":"https://secwatch.observer/filing/0001641172-25-004799.json","markdown":"https://secwatch.observer/filing/0001641172-25-004799.md","text":"https://secwatch.observer/filing/0001641172-25-004799.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225004799/0001641172-25-004799-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815974/000164117225004799/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T14:52:11.619270+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}